Document is current
Any future updates will be listed below
-
Authors
Wu, Keyi
Ren, Qin
Wang, Yanli
Zhou, Yannan
Liu, Zhengzhi
Cheng, Yang
Deng, Qiaohuan
Cui, Yingzi
Yang, Haimiao https://orcid.org/0000-0002-2863-6516
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06768619 at ClinicalTrials.govDocuments that mention this clinical trial
A Single-Center, Randomized, Open-Label, Two-Formulation, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of Two Eltrombopag Olamine Tablets (25 mg) in Healthy Chinese Subjects in the Fed State
https://doi.org/10.1007/s40261-026-01528-0
-
Funding
Funding for this research was provided by:
Funding This work was supported by Chia Tai Tianqing Pharmaceutical Group Co.,Ltd, Jiangsu, China, (funding number: phase I 2019-004)
- License Information
-
More Information
Article History
Received: 18 May 2025
Accepted: 19 January 2026
First Online: 7 February 2026
Declarations
:
: All data related to this study were interpreted by the trial staff with complete independence from the sponsor. Qin Ren, Yanli Wang, Yannan Zhou, Zhengzhi Liu, Yang Cheng, Qiaohuan Deng, Yingzi Cui, and Haimiao Yang are employees of the Affiliated Hospital of Changchun University of Chinese Medicine and Keyi Wu is an employee of Chia Tai Tianqing Pharmaceutical Group Co., Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in the subject matter or materials discussed in the article apart from those disclosed.
: This study was approved by the Ethics Committee of the Affiliated Hospital of Changchun University of Chinese Medicine (date: 2023.02.10, No. CCZYFYLL2023). All procedures followed were in accordance with the ethical standards set out in the Declaration of Helsinki.
: Written informed consent was obtained from all participants included in the study.
: Not applicable.
: We confirm that the figures and tables in this article are original and have not been published before. The data that support the findings of this study are available from the corresponding author upon reasonable request but remain subject to all applicable legal requirements to protect the confidentiality of the study subjects’ personal information.
: Not applicable.
: HY and YC contributed to the conception and design of the study. QR, YW, YZ, YC, and ZL were responsible for material preparation and data collection. KW and QD drafted the initial version of the manuscript. YC and HY critically reviewed and approved the final manuscript. All authors read and approved the final version and agree to be accountable for all aspects of the work.
